Skip to main content

Newsroom

Latest News

July 9, 2012

WASHINGTON, D.C. – The House of Representatives passed H.R. 5892, the Hydropower Regulatory Efficiency Act, by a vote of 372-0 today. This bipartisan bill – authored by U.S. Reps.

July 3, 2012

DENVER – Today, U.S. Rep. Diana DeGette (CO-1) announced that immediately upon the House returning to session next Monday, she will be introducing a bill she has written to ensure firefighters bravely fighting these wildfires receive health insurance.

July 2, 2012

DENVER – Today U.S. Rep. Diana DeGette (CO-1) celebrated the U.S. Patent and Trademark Office's (USPTO) selection of Denver to serve as home for one of three new satellite patent offices. The new office is estimated to generate $440 million in economic development activity in the First District and across the state over the next five years.

Rep. DeGette's statement is as follows:

June 20, 2012

Washington, D.C. – The House Energy and Commerce Committee passed HR, 5892, the Hydropower Regulatory Efficiency Act of 2012 today. This bipartisan bill – authored by Rep. Diana DeGette (D-CO) and Rep.

June 19, 2012

WASHINGTON – U.S. Rep. Diana DeGette (CO-1) today issued the following opening statement at the so-called “Federal Green Jobs Agenda” hearing of the House Energy and Commerce’s Subcommittee on Oversight and Investigations. As Ranking Member of the Subcommittee, Rep.

June 15, 2012

Screaming Trees

June 15, 2012

Image removed.

By: Sophie Quinton

June 14, 2012

Diana DeGette's clean-energy tour to Coolerado, RavenBrick

June 14, 2012

Image removed.

By: Sam Levin

June 7, 2012

Washington, D.C. – Rep. Diana DeGette (D-CO) and Rep. Cathy McMorris Rodgers (R-WA), authors of HR 5892, the Hydropower Regulatory Efficiency Act of 2012, applauded the House Energy & Power Subcommittee’s approval of their bill today.

June 4, 2012

FDA overhaul a rare display of bipartisanship in Congress

June 4, 2012

Image removed.

By: Allison Sherry

May 31, 2012

Today, a memo was circulated to Democratic Members of the Energy and Commerce Committee that summarizes the role of the Pharmaceutical Research and Manufacturers of America (PhRMA) in the passage of the Affordable Care Act.